First Wave BioPharma Price on July 21, 2023

FWBIDelisted Stock  USD 0.61  0.03  4.69%   
If you're considering investing in First Stock, it is important to understand the factors that can impact its price. As of today, the current price of First Wave stands at 0.61, as last reported on the 12th of December 2024, with the highest price reaching 0.66 and the lowest price hitting 0.59 during the day. We have found twenty-four technical indicators for First Wave BioPharma, which you can use to evaluate the volatility of the firm. Please confirm First Wave's Standard Deviation of 8.39, mean deviation of 5.73, and Variance of 70.44 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
First Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FWBI
Based on monthly moving average First Wave is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of First Wave by adding First Wave to a well-diversified portfolio.

First Wave Valuation on July 21, 2023

It is possible to determine the worth of First Wave on a given historical date. On July 21, 2023 First was worth 0.67 at the beginning of the trading date compared to the closed value of 0.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of First Wave stock. Still, in general, we apply an absolute valuation method to find First Wave's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of First Wave where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against First Wave's related companies.
 Open High Low Close Volume
  0.70    0.72    0.65    0.67    307,213  
07/21/2023
  0.67    0.70    0.61    0.64    346,432  
  0.64    0.66    0.59    0.61    182,153  
Backtest First Wave  |  First Wave History  |  First Wave Valuation   PreviousNext  
Open Value
0.67
0.64
Closing Value
0.67
Upside

First Wave Trading Date Momentum on July 21, 2023

On July 24 2023 First Wave BioPharma was traded for  0.61  at the closing time. The top price for the day was 0.66  and the lowest listed price was  0.59 . The trading volume for the day was 182.2 K. The trading history from July 24, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.69% . The overall trading delta against the current closing price is 0.00% .

First Wave BioPharma Fundamentals Correlations and Trends

By evaluating First Wave's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among First Wave's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. First financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About First Wave Stock history

First Wave investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for First is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in First Wave BioPharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing First Wave stock prices may prove useful in developing a viable investing in First Wave
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. First Wave BioPharma, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida. First Wave operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.

First Wave Stock Technical Analysis

First Wave technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of First Wave technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of First Wave trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

First Wave Period Price Range

Low
December 12, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

First Wave BioPharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

First Wave December 12, 2024 Market Strength

Market strength indicators help investors to evaluate how First Wave stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading First Wave shares will generate the highest return on investment. By undertsting and applying First Wave stock market strength indicators, traders can identify First Wave BioPharma entry and exit signals to maximize returns

First Wave Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for First Wave's price direction in advance. Along with the technical and fundamental analysis of First Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of First to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in First Stock

If you are still planning to invest in First Wave BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the First Wave's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bonds Directory
Find actively traded corporate debentures issued by US companies